Our findings revealed that RSPO2 alterations occurred more frequently than those in other family members, as well as canonical Wnt regulators CTNNB1 and APC, providing insight into its potential significance in prostate cancer progression. This evidence concerns the gene RSPO2 and prostate carcinoma.